User:Nathalie Juge - Revision history

Harry Brumer: standardized picture format

2011-02-08T20:09:35Z

standardized picture format

Harry Brumer: changed photo position

2010-10-14T14:26:11Z

changed photo position

Nathalie Juge at 12:54, 13 October 2010

2010-10-13T12:54:34Z

Nathalie Juge at 12:53, 13 October 2010

2010-10-13T12:53:33Z

Nathalie Juge at 12:51, 13 October 2010

2010-10-13T12:51:48Z

Nathalie Juge at 12:49, 13 October 2010

2010-10-13T12:49:41Z

Nathalie Juge at 12:49, 13 October 2010

2010-10-13T12:49:02Z

Nathalie Juge at 12:48, 13 October 2010

2010-10-13T12:48:39Z

Nathalie Juge at 12:46, 13 October 2010

2010-10-13T12:46:44Z

Nathalie Juge at 12:25, 13 October 2010

2010-10-13T12:25:42Z

← Older revision		Revision as of 20:09, 8 February 2011
Line 1:		Line 1:
−	[[File:Nathalie-Juge.jpg~~\|thumb~~\|200px\|right]]	+	[[File:Nathalie-Juge.jpg\|200px\|right]]

	Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite> and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>), her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]]) <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion (<cite>MacKenzie2009</cite>).		Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite> and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>), her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]]) <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion (<cite>MacKenzie2009</cite>).

← Older revision		Revision as of 14:26, 14 October 2010
Line 1:		Line 1:
−	[[File:Nathalie-Juge.jpg]]	+	[[File:Nathalie-Juge.jpg\|thumb\|200px\|right]]

	Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite> and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>), her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]]) <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion (<cite>MacKenzie2009</cite>).		Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite> and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>), her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]]) <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion (<cite>MacKenzie2009</cite>).

← Older revision		Revision as of 12:54, 13 October 2010
Line 1:		Line 1:
	[[File:Nathalie-Juge.jpg]]		[[File:Nathalie-Juge.jpg]]

−	Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite> and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>) , her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]]) <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion (<cite>MacKenzie2009</cite>).	+	Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite> and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>), her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]]) <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion (<cite>MacKenzie2009</cite>).

@@ Line 7: / Line 7: @@
 ----
+<biblio>
-# Tribolo2007 pmid=17555766
+#Tribolo2007 pmid=17555766
-# Jugeb2006 pmid=16774842
+#Jugeb2006 pmid=16774842
-# Durand2005 pmid=15794761
+#Durand2005 pmid=15794761
-# Payan2004 pmid=15181003
+#Payan2004 pmid=15181003
-# Berrin2003 pmid=12667141
+#Berrin2003 pmid=12667141
-# Giardina2001 pmid=11700070
+#Giardina2001 pmid=11700070
-# Juge1995 pmid=7737421
+#Juge1995 pmid=7737421
-# Jugea2006 pmid=16403494
+#Jugea2006 pmid=16403494
-# AndreLeroux2008 pmid=18384043
+#AndreLeroux2008 pmid=18384043
-# MacKenzie2009 pmid=19758995
+#MacKenzie2009 pmid=19758995

@@ Line 1: / Line 1: @@
 [[File:Nathalie-Juge.jpg]]
-Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite>  and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>) , her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]] <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion.
+Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite>  and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>) , her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]]) <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion (<cite>MacKenzie2009</cite>).
@@ Line 8: / Line 8: @@
 ----
-#Tribolo2007 pmid=17555766
+# Tribolo2007 pmid=17555766
-#Jugeb2006 pmid=16774842
+# Jugeb2006 pmid=16774842
-#Durand2005 pmid=15794761
+# Durand2005 pmid=15794761
-#Payan2004 pmid=15181003
+# Payan2004 pmid=15181003
-#Berrin2003 pmid=12667141
+# Berrin2003 pmid=12667141
-#Giardina2001 pmid=11700070
+# Giardina2001 pmid=11700070
-#Juge1995 pmid=7737421
+# Juge1995 pmid=7737421
-#Jugea2006 pmid=16403494
+# Jugea2006 pmid=16403494
-#AndreLeroux2008 pmid=18384043
+# AndreLeroux2008 pmid=18384043

← Older revision		Revision as of 12:49, 13 October 2010
Line 1:		Line 1:
	[[File:Nathalie-Juge.jpg]]		[[File:Nathalie-Juge.jpg]]

−	Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite> and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors <cite>Jugeb2006</cite> , her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]] <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion.	+	Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite> and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors (for a review, see <cite>Jugeb2006</cite>) , her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]]) <cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]] <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion.

@@ Line 1: / Line 1: @@
 [[File:Nathalie-Juge.jpg]]
-Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]). After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) and starch binding domain (CBM20), she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors, her Group focusing on xylanases ([[GH10]] & [[GH11]]) and xylanase inhibitors ([[GH18]]), and supervising a project on human beta-glucosidase ([[GH1]]). She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion.
+Nathalie Juge started working on carbohydrate-active enzymes during her PhD she obtained in 1993 in Marseille (France) on the structure-function studies of barley alpha-amylases ([[GH13]]) (see for example <cite>Juge1995</cite>. After two post-doctoral positions in Carlsberg, Copenhagen, Denmark (on EMBO fellowship and EU contract) with Birte Svensson, and a Marie-Curie fellowship at the Institute of Food Research (IFR, Norwich, UK) on glucoamylase ([[GH15]]) <cite>Giardina2001</cite>  and starch binding domain (CBM20) <cite>Jugea2006</cite>, she moved back to Marseille as a lecturer in 1997. She then spent several years as visiting scientist at IFR where she coordinated an EU project on glycosidase inhibitors <cite>Jugeb2006</cite> , her Group focusing on xylanases ([[GH10]] & [[GH11]]) (see for example <cite>AndreLeroux2008</cite>) and xylanase inhibitors ([[GH18]])<cite>Durand2005 Payan2004</cite> , and supervising a project on human beta-glucosidase ([[GH1]] <cite>Tribolo2007 Berrin2003</cite>. She recently joined the Integrated Biology of the Gastrointestinal Tract programme at IFR to lead a Group focusing on the molecular mechanisms underlying bacteria-mucus interactions and the role of protein-glycan interactions in the control of bacterial adhesion.
 [[Category:Contributors|Juge, Nathalie]]